Aeinehband S, Brenner P, Ståhl S, Bhat M, Fidock MD, Khademi M, Olsson T, Engberg G, Jokinen J, Erhardt S (2016) Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms. Brain Behav Immun 51:47–55

Article  CAS  PubMed  Google Scholar 

Agudelo LZ, Femenía T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, Correia JC, Izadi M, Bhat M, Schuppe-Koistinen I (2014) Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159(1):33–45

Article  CAS  PubMed  Google Scholar 

Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Saad HM, Batiha GE-S, Klionsky DJ (2024) The beneficial role of autophagy in multiple sclerosis: yes or no? Autophagy 20(2):259–274

Article  CAS  PubMed  Google Scholar 

Allison DJ, Nederveen JP, Snijders T, Bell KE, Kumbhare D, Phillips SM, Parise G, Heisz JJ (2019) Exercise training impacts skeletal muscle gene expression related to the kynurenine pathway. Am J Physiol Cell Physiol. https://doi.org/10.1152/ajpcell.00448.2018

Article  PubMed  PubMed Central  Google Scholar 

Areces F, González-Millán C, Salinero JJ, Abian-Vicen J, Lara B, Gallo-Salazar C, Ruiz-Vicente D, Del Coso J (2015) Changes in serum free amino acids and muscle fatigue experienced during a half-ironman triathlon. PLoS ONE 10(9):e0138376

Article  PubMed  PubMed Central  Google Scholar 

Atakan MM, Li Y, Koşar ŞN, Turnagöl HH, Yan X (2021) Evidence-based effects of high-intensity interval training on exercise capacity and health: a review with historical perspective. Int J Environ Res Public Health 18(13):7201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R (2024) Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases. Front Immunol 15:1421346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahmani E, Hoseini R, Amiri E (2022a) The effect of home-based aerobic training and vitamin D supplementation on fatigue and quality of life in patients with multiple sclerosis during COVID-19 outbreak. Sci Sports 37(8):710–719

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahmani E, Hoseini R, Amiri E (2022b) Home-based aerobic training and vitamin D improve neurotrophins and inflammatory biomarkers in MS patients. Mult Scler Relat Disord 60:103693

Article  CAS  PubMed  Google Scholar 

Bansi J, Koliamitra C, Bloch W, Joisten N, Schenk A, Watson M, Kool J, Langdon D, Dalgas U, Kesselring J (2018) Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training. J Neuroimmunol 314:101–105

Article  CAS  PubMed  Google Scholar 

Barry A, Cronin O, Ryan AM, Sweeney B, Yap SM, O’Toole O, Allen AP, Clarke G, O’Halloran KD, Downer EJ (2016) Impact of exercise on innate immunity in multiple sclerosis progression and symptomatology. Front Physiol 7:194

Article  PubMed  PubMed Central  Google Scholar 

Barzegar M, Vaheb S, Mirmosayyeb O, Ashtari F, Afshari-Safavi A, Adibi I, Shaygannejad A, Mazaheri S, Rahimi M (2024) Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: a population-based study. Mult Scler Relat Disord 84:105479

Article  PubMed  Google Scholar 

Bello C, Heinisch PP, Mihalj M, Carrel T, Luedi MM (2021) Indoleamine-2, 3-dioxygenase as a perioperative marker of the immune system. Front Physiol 12:766511

Article  PubMed  PubMed Central  Google Scholar 

Biernacki T, Sandi D, Bencsik K, Vécsei L (2020) Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives. Cells 9(6):1564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:IJTR. S2097

Article  Google Scholar 

Chen Y, Zhang J, Yang Y, Xiang K, Li H, Sun D, Chen L (2022) Kynurenine-3-monooxygenase (KMO): from its biological functions to therapeutic effect in diseases progression. J Cell Physiol 237(12):4339–4355

Article  CAS  PubMed  Google Scholar 

DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 115(1):89–97

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eva L, Pleș H, Covache-Busuioc R-A, Glavan LA, Bratu B-G, Bordeianu A, Dumitrascu D-I, Corlatescu AD, Ciurea AV (2023) A comprehensive review on neuroimmunology: insights from multiple sclerosis to future therapeutic developments. Biomedicines 11(9):2489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fakan B, Szalardy L, Vecsei L (2019) Exploiting the therapeutic potential of endogenous immunomodulatory systems in multiple sclerosis—special focus on the peroxisome proliferator-activated receptors (PPARs) and the kynurenines. Int J Mol Sci 20(2):426

Article  PubMed  PubMed Central  Google Scholar 

Fan R, Kong J, Zhang J, Zhu L (2024) Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions. Front Med 11:1471642

Article  Google Scholar 

Fathi M, Vakili K, Yaghoobpoor S, Tavasol A, Jazi K, Mohamadkhani A, Klegeris A, McElhinney A, Mafi Z, Hajiesmaeili M (2022) Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: a systematic review. Front Immunol 13:1013784

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Fátima Alves L, Moore JB, Kell DB (2024) The biology and biochemistry of kynurenic acid, a potential nutraceutical with multiple biological effects. Int J Mol Sci 25(16):9082

Article  Google Scholar 

Fransson ME, Liljenfeldt LS, Fagius J, Tötterman TH, Loskog AS (2009) The T-cell pool is anergized in patients with multiple sclerosis in remission. Immunology 126(1):92–101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galota F, Marcheselli S, De Biasi S, Gibellini L, Vitetta F, Fiore A, Smolik K, De Napoli G, Cardi M, Cossarizza A (2025) Impact of high-efficacy therapies for multiple sclerosis on B cells. Cells 14(8):606

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221(1–2):7–14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grishanova AY, Perepechaeva ML (2024) Kynurenic acid/AhR signaling at the junction of inflammation and cardiovascular diseases. Int J Mol Sci 25(13):6933

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L (2005a) Kynurenine metabolism in multiple sclerosis. Acta Neurol Scand 112(2):93–96

Article  CAS  PubMed  Google Scholar 

Herman S, Åkerfeldt T, Spjuth O, Burman J, Kultima K (2019) Biochemical differences in cerebrospinal fluid between secondary progressive and relapsing–remitting multiple sclerosis. Cells 8(2):84

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hinkley JM, Yu GX, Standley RA, Distefano G, Tolstikov V, Narain NR, Greenwood BP, Karmacharya S, Kiebish MA, Carnero EA (2023) Exercise and ageing impact the kynurenine/tryptophan pathway and acylcarnitine metabolite pools in skeletal muscle of older adults. J Physiol 601(11):2165–2188

Article  CAS  PubMed